Novel Drugs updates

Several innovative drug delivery technologies have gathered notable momentum (in terms of adoption and sales) soon after entering the market; most of these are designed to address the unmet needs of administering complex pharmacological interventions Roots Analysis has announced the addition of the “ On-body Drug Delivery Devices - Intellectual Property Landscape: Focus on Popular / Relevant Prior Art Search Expressions, Patent Valuation, Pockets of Innovation / White Spaces, and Key Applicant Profiles ” report to its list of offerings.   Since the early 20th century, over 12,000 patents / patent applications have been granted / filed in relation to drug delivery devices that can either be worn on the body ( or implanted ), by both industry and non-industry players. Presently, innovation in this domain is focused on developing cheaper and more environment friendly drug delivery systems, with provisions to minimize / altogether eliminate the risk of needlestick injuries. ...

With multiple approved products, the field of stem cell therapies has gained substantial momentum over the last decade; several innovator companies are currently progressing their proprietary therapy candidates with cautious op            timism. In fact, recent studies suggest that mesenchymal stem cells have the potential to end the Coronavirus (COVID-19) pandemic .   Roots Analysis is pleased to announce the publication of its recent study, titled, “ Global Stem Cells Market : Focus on Clinical Therapies, 2020–2030 (Based on Source (Allogeneic, Autologous); Origin (Adult, Embryonic); Type (Hematopoietic, Mesenchymal, Progenitor); Lineage (Amniotic Fluid, Adipose Tissue, Bone Marrow, Cardiosphere, Chondrocytes, Corneal Tissue, Cord Blood, Dental Pulp, Neural Tissue Placenta, Peripheral Blood, Stromal Cells); and Potency (Multipotent, Pluripotent)) ”.   The   report features an extensive study of the curre...